» Articles » PMID: 35383484

Targeting Oxidative Stress and Inflammatory Response for Blood-Brain Barrier Protection in Intracerebral Hemorrhage

Overview
Specialty Endocrinology
Date 2022 Apr 6
PMID 35383484
Authors
Affiliations
Soon will be listed here.
Abstract

Blood-brain barrier (BBB) disruption is a major pathological change after intracerebral hemorrhage (ICH) and is both the cause and result of oxidative stress and of the immune response post-ICH. These processes contribute to ICH-induced brain injury. After the breakdown of cerebral vessels, blood components, including erythrocytes and their metabolites, thrombin, and fibrinogen, can access the cerebral parenchyma through the compromised BBB, triggering oxidative stress and inflammatory cascades. These aggravate BBB disruption and contribute to further infiltration of blood components, resulting in a vicious cycle that exacerbates brain edema and neurological injury after ICH. Experimental and clinical studies have highlighted the role of BBB disruption in ICH-induced brain injury. In this review, we focus on the strategies to protect the BBB in ICH. Specifically, we summarize the evidence and the underlying mechanisms, including the ICH-induced process of oxidative stress and inflammatory response, and we highlight the potential therapeutic targets to protect BBB integrity after ICH. Future studies should probe the mechanism of ferroptosis as well as oxidative stress-inflammation coupling in BBB disruption after ICH and investigate the effects of antioxidants and immunomodulatory agents in more ICH clinical trials. 37, 115-134.

Citing Articles

Jugular Vein Evans Blue Injection for Blood-Brain Barrier Assessment Following Hemorrhagic Stroke in a Mouse Model.

Zeng Y, Wang F, Liu R, Xiong T, Liu G, Yin H Transl Stroke Res. 2025; .

PMID: 40075049 DOI: 10.1007/s12975-025-01341-5.


Influx of Metabolites into Cerebrospinal Fluid in Intracerebral Hemorrhage is Associated with Increased Central Inflammation: a Retrospective Observational Study.

Zhang H, Zhong Y, Shao J, Sun K, Zhang L, Zhang Y Transl Stroke Res. 2025; .

PMID: 40069432 DOI: 10.1007/s12975-025-01342-4.


Microglial Mechanisms and Therapeutic Potential in Brain Injury Post-Intracerebral Hemorrhage.

Gong Y, Li H, Cui H, Gong Y J Inflamm Res. 2025; 18:2955-2973.

PMID: 40026311 PMC: 11872102. DOI: 10.2147/JIR.S498809.


Association between serum total bilirubin levels and 28-day all-cause mortality after intracerebral hemorrhage.

Qiu D, Li G, Dong Y Front Neurol. 2025; 16:1529415.

PMID: 40013002 PMC: 11860087. DOI: 10.3389/fneur.2025.1529415.


Role of the platelet-lymphocyte ratio as a prognostic indicator in patients with intracranial hemorrhage: A systematic review and meta-analysis.

Yuan X, Zhang S, Wan J, Yang J, Deng Y, Feng Y PLoS One. 2025; 20(2):e0311153.

PMID: 39929080 PMC: 11810451. DOI: 10.1371/journal.pone.0311153.